期刊文献+

5-Aza-CdR干扰人子宫内膜样癌JEC细胞后ER拮抗剂对细胞增殖、形态及p57^(kip2)蛋白表达的影响

Effects of estrogen receptor antagonist on cell proliferation and morphology and the p57^(kip2)protein expression in human endometrioid carcinoma JEC cells after 5-Aza-CdR pretreatment
下载PDF
导出
摘要 目的探讨5-氮杂-2′-脱氧胞苷(5-Aza-2’-deoxycytidine,5-Aza-CdR)预处理人子宫内膜样癌(Endometrioid carcinoma,EC)JEC细胞后,雌激素受体(Estrogen receptor,ER)拮抗剂他莫昔芬(Tamoxifen,TAM)、氟维司群(ICI-182780,ICI)对JEC细胞生长、形态改变及p57^(kip2)蛋白表达的影响。方法将JEC细胞用5-Aza-CdR处理后,用亚硫酸氢盐测序(Bisulfite sequencing PCR,BSP)法检测细胞中p57^(kip2)启动子区的甲基化率。将JEC细胞分为6组:对照组、雌二醇(β-estradiol,E_(2))组、TAM组、ICI组、E_(2)+TAM组、E_(2)+ICI组,待5-Aza-CdR处理后,用甲基偶氮唑盐比色(MTT)法检测各组细胞培养24、48、72 h的增殖活性;用光镜和电镜观察培养72 h时细胞的形态改变,用蛋白印迹(Western blot)法检测培养72 h时细胞中p57^(kip2)蛋白的表达情况。结果用5-Aza-CdR处理后,JEC细胞中p57^(kip2)启动子区甲基化率从81.1%降为76.2%。与对照组比较,细胞增殖活性在E_(2)组均升高,在ICI组、E_(2)+TAM组、E_(2)+ICI组则均降低,且均在24 h改变最明显(P<0.05)。对照组细胞呈圆形或类圆形,细胞游离缘见少量微绒毛;与对照组相比,E_(2)组细胞密度明显升高,E_(2)+TAM组密度明显降低;在TAM组、ICI组、E_(2)+TAM组、E_(2)+ICI组中,可见更多的分泌泡,在TAM组、E_(2)+ICI组则可见明显的凋亡小体。与对照组比较,在E_(2)组中p57^(kip2)蛋白表达减少(P<0.05),在ICI组、E_(2)+TAM组、E_(2)+ICI组中p57^(kip2)蛋白表达均增高(P<0.05),以E_(2)+TAM组增高最明显。结论5-Aza-CdR可下调JEC细胞中p57^(kip2)基因启动子区的高甲基化水平,从而恢复抑癌因子p57^(kip2)的生物活性,逆转TAM对JEC细胞的弱雌激素样作用,增强ICI对JEC细胞增殖的抑制作用;还可能协同TAM、ICI上调p57^(kip2)蛋白的表达水平,拮抗E_(2)对p57^(kip2)蛋白水平的下调作用,达到削弱CDK的激酶活性,从而发挥负向调控细胞周期、抑制JEC细胞进一步生长的作用。 Objective To investigate the effects of estrogen receptor(ER)antagonist tamoxifen(TAM)and ICI-182780(ICI)on cell proliferation,morphology and the cell-cycle inhibitor p57^(kip2)protein expression in human endometrioid carcinoma JEC cells after demethylation agent 5-Aza-2’-deoxycytidine(5-Aza-CdR)pretreatment.Methods JEC cells were pretreated with 5-Aza-CdR followed by the treatments withβ-estradiol(E_(2)),TAM,ICI,E_(2)+TAM,E_(2)+ICI,and vehicle,respectively.Cell proliferation was determined by MTT assay at 24,48 and 72 h.Cell morphology was examined at 72 h under light and electron microscopy.The expression of p57^(kip2)protein was determined at 72 h by Western blot analysis.Results The methylation rate of p57^(kip2)protein was decreased by 5-Aza-CdR pretreatment from 81.1%to 76.2%.E_(2)increased cell proliferation.Cell proliferation was decreased in ICI,E_(2)+TAM and E_(2)+ICI groups,especially at 24 h.Control cells were round with a bit of microvilli on the edge of cells.The cell density was increased by E_(2)and decreased in E_(2)+TAM groups.More secretory vesicles were observed in TAM,ICI,E_(2)+TAM and E_(2)+ICI groups.Apoptotic bodies were found in TAM and E_(2)+ICI groups.Compared to control group,E_(2)decreased the expression of p57^(kip2)protein,while p57^(kip2)protein was increased in ICI,E_(2)+TAM and E_(2)+ICI groups.Conclusion 5-Aza-CdR decreases the hyper-methylation of the promoter region of p57^(kip2)gene and enhances the anti-proliferation effect of ICI and TAM against E_(2).Thus,5-Aza-CdR could act synergistically with TAM and ICI to decrease the kinase activity of CDK and negatively regulate cell cycle to inhibit estrogen-responsive JEC cells growth.
作者 钟栎 周俊 张春英 周正平 Zhong Yue;Zhou Jun;Zhang Chunying;Zhou Zhengping(Department of Pathology,the Affiliated Hospital of Zunyi Medical University,Zunyi Guizhou 563099,China;Department of Electron Microscopy,Zunyi Medical University,Zunyi Guizhou 563099,China;Department of Pathology,Zunyi Medical University,Zunyi Guizhou 563099)
出处 《遵义医科大学学报》 2021年第1期1-8,共8页 Journal of Zunyi Medical University
基金 贵州省科技合作计划资助项目(NO:黔科合基础[2017]1216)。
关键词 子宫内膜癌 雌激素受体拮抗剂 5-氮杂-2′-脱氧胞苷 p57 kip2 endometrial cancer estrogen receptor antagonist 5-Aza-CdR p57^(kip2)
  • 相关文献

参考文献8

二级参考文献69

  • 1张宇馨,蔡卫民.他莫昔芬的遗传药理学研究及其临床应用[J].世界临床药物,2009,30(11):698-701. 被引量:8
  • 2冯长根,邓霞飞,向华,廖清江.治疗乳腺癌的抗雌激素药物研究进展[J].中国新药杂志,2006,15(13):1051-1057. 被引量:13
  • 3陈孝平,汪建平.外科学[M].8版.北京:人民卫生出版社,2013:408-409. 被引量:317
  • 4Siegel RL, Miller KD, Jemal A. Cancer statistics [ J ]. CA Cancer J Clin ,2015,65 ( 1 ) :5 - 29. 被引量:1
  • 5ACOG, SGO. Practice bulletin no. 149 :endometrial cancer[ J]. Obstet Gyueco1,2015,125 (4) : 1006 - 1026. 被引量:1
  • 6Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States,2015:a review of current American Cancer Soci- ety guidelines and current issues in cancer screening[ J]. CA Cancer J Clin,2015,65( 1 ) :30 -54. 被引量:1
  • 7NCCN Clinical Practice Guidelines in Oncology( NCCN Guidelines) Genetic/Familial High-Rish Assessment: Colorectal [ J/OL ]. Lynch Syndrome. Version I 2015. http ://www. nccn. org/professionals/phy- sician_gls/pdf/genetics_colon, pdf 的 L3 - 3. 被引量:1
  • 8Schmeler KM, Daniels MS, Brandt AC,et al. Endometrial cancer in an adolescent : a possible manifestation of Cowden syndrome [ J ]. Obstet Gynecol,2009,114 ( 2 ) :477 - 479. 被引量:1
  • 9Mc Cann SE, Freudenheim JL, Marshall JR, et al. Diet in the epidemi- ology of endometrial cancer in westem New York ( United States) [ J ]. Cancer Causes Control,2000,11 (10) :965 - 974. 被引量:1
  • 10Houston TP,Elster AB ,Davis RM,et al. The U. S. preventive services task force guide to clinical preventive services, second edition [ J ]. AMA Council on Scientific Affairs ,Am J Prey Med ,1998,14(4) :374 -376. 被引量:1

共引文献671

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部